Thomas Braxton King's Insider Trades & SAST Disclosures
Thomas Braxton King's most recent trade in Achieve Life Sciences Inc. was a trade of 455,000 Performance Restricted Stock Unit (PRSU) done . Disclosure was reported to the exchange on Jan. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas Braxton King.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc. | Thomas Braxton King | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 455,000 | 455,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc. | Thomas Braxton King | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 195,000 | 195,000 | - | - | Stock Option (right to buy) | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 1,583 | 1,583 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 1,583 | 1,583 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 3,110 | 3,110 | - | - | Restricted stock units | |
| Achieve Life Sciences Inc. | Thomas King Braxton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges